SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-022778
Filing Date
2024-02-14
Accepted
2024-02-14 06:28:12
Documents
1
Group Members
CHRISTOPHER HINKELRADCLIFFE SPAC GP, LLCRADCLIFFE SPAC MASTER FUND, L.P.RGC MANAGEMENT COMPANY, LLCSTEVEN B. KATZNELSON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245838d19_sc13ga.htm SC 13G/A 145729
  Complete submission text file 0001104659-24-022778.txt   147696
Mailing Address 50 MONUMENT ROAD, SUITE 300 BALA CYNWYD PA 19004
Business Address 50 MONUMENT ROAD, SUITE 300 BALA CYNWYD PA 19004 6106175900
Radcliffe Capital Management, L.P. (Filed by) CIK: 0001218275 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Subject) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92283 | Film No.: 24632024
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)